Method for detecting oxidative damage based on fluorescent oxidation product
Through the detection method based on fluorescent oxidation products, the existing detection methods of oxidation damage markers are solved, and the detection of oxidation damage with high sensitivity and strong specificity is achieved, and a reasonable priced rapid detection kit is provided. , used to screen people with abnormal levels of oxidative damage and reduce the risk of disease.
Patent Information
- Application Number
- CN202411288113.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-14
- Publication Date
- 2024-11-12
AI Technical Summary
The existing detection methods for oxidative damage markers have problems such as low sensitivity, insufficient specificity, complex detection and high cost. In particular, traditional detection methods for oxidative damage markers such as malondialdehyde and 8-hydroxyguanosine are difficult to meet clinical needs. .
Using a detection method based on fluorescent oxidation products (FlOPs), the detection of FlOP_360 and FlOP_400 was detected through standardized detection procedures and standard reference materials, combined with a microplate reader, the fluorescence intensity measurement of sample plasma and the calculation of the concentration of oxidative damage product were realized.
Improve the sensitivity and specificity of the detection, reduce the detection cost, and provide a low-priced, high-specificity and wide-ranging FlOPs standardized rapid detection kit, which can effectively screen people with abnormal oxidative damage levels and reduce the risk of related diseases. .
Smart Images

Figure CN118937294A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of medical detection technology, and in particular relates to a method for detecting oxidative damage based on fluorescent oxidation products. Background Art
[0002] Oxidative damage refers to the damage and destruction caused by the accumulation of reactive oxygen species in the body or cells through oxidative reactions such as respiratory metabolism. It is mainly manifested in oxidative damage to lipids, DNA, sugars and proteins. Oxidative damage leads to the destruction of cell structure and function, damage to body tissues and organ lesions, and even cancer. Oxidative damage is closely related to the occurrence and development of many diseases. Paying attention to oxidative damage markers can understand the extent of oxidative damage in the body and thus assess the risk of disease. Commonly used oxidative damage markers include traditional oxidative damage markers and new oxidative damage markers.
[0003] Traditional oxidative damage markers include malondialdehyde (MDA), 8-hydroxyguanosine (8-OHdg), pentosidine (PTD), and nitrotyrosine (NT). Traditional oxidative damage markers have many shortcomings. First, the sensitivity of reflecting the level of total oxidative damage is poor, and it can only reflect the oxidation products of single lipids, sugars, proteins, and DNA; in addition, the test sample requires the test blood sample to be fresh, which is difficult to promote in the future; and the commercially available MDA, 8-OHdg, PTD, and NTElisa kits are expensive. In addition to the above-mentioned traditional oxidative damage markers, the nonspecific oxidative damage indicator homocysteine, which is commonly used in clinical practice, also has high detection requirements and costs.
[0004] Compared with traditional oxidative damage markers, the new oxidative damage marker - fluorescent oxidation products (FlOPs) has the advantages of high sensitivity, strong specificity, good stability and simple measurement method. The detection sensitivity is 10-100 times that of the malondialdehyde test kit, and the FlOPs level is not associated with the inflammatory factor C-reactive protein. It has strong specificity and high market application value. However, in recent years, the method for detecting FlOPs is generally fluorescence spectrophotometry, but the amount of blood sample required for detection is large, the operation is inconvenient, and the detection speed is slow. Therefore, it is particularly important to find a product for detecting oxidative damage with strong specificity, high sensitivity, stable detection and relatively ideal cost. Summary of the invention
[0005] The purpose of the present invention is to provide a method for detecting oxidative damage based on fluorescent oxidation products, aiming to solve the problems raised in the above background technology.
[0006] To achieve the above object, the present invention provides the following technical solutions:
[0007] A method for detecting oxidative damage based on fluorescent oxidation products comprises the following steps:
[0008] Step S1, detecting the fluorescence intensity of sample plasma; specifically comprising the following steps:
[0009] Step S11, thawing / cooling: extracting a blood sample by centrifugation to obtain a plasma sample. When using, thaw the pre-frozen plasma sample in a 4°C refrigerator or cool the newly collected centrifuged plasma sample to a 4°C refrigerator;
[0010] Step S12, preparing an extractant: using anhydrous ethanol and ether in a volume ratio of 3:1;
[0011] Step S13, preparing plasma and extractant: mixing plasma and extractant at a volume ratio of 1:20, preparing three tubes, each with a solution volume of 1300 μL;
[0012] Step S14, sample processing: placing the EP tube on a shaker for shaking, then centrifuging the EP tube, after the centrifugation is completed, transferring the supernatant in the EP tube to a new EP tube, and centrifuging again;
[0013] Step S15, detection: the three sets of parallel solutions are placed in three Corning plates for measurement, the solution of each EP tube is dripped into three wells, and the plate is placed in an ELISA reader for detection;
[0014] The parameter settings of the microplate reader include: fluorescence measurement, excitation wavelengths are 360 nm and 400 nm, and the corresponding emission wavelengths are 420 nm and 475 nm; the wavelengths correspond to two FlOP products, namely FlOP_360 and FlOP_400;
[0015] Step S16, calculation: finding the average fluorescence intensity of the three Corning plates at the same volume ratio to obtain the fluorescence intensity of the plasma sample to be tested;
[0016] Step S2, standard reference substance control; specifically comprises the following steps:
[0017] Step S21, preparing 1000 mL of 0.05 mol / L H2SO4 solution;
[0018] Step S22, preparing 3.0-6.0 μg / mL quinine sulfate solution as a standard reference;
[0019] Step S23, preparing an extractant: using anhydrous ethanol and ether in a volume ratio of 3:1;
[0020] Step S24, prepare standard reference substances and extractants at volume ratios of 1:5, 1:10, 1:15, 1:20, 1:25, 1:30, and 1:50 respectively and place them in EP tubes, with the volume of solution in each tube being 1300 μL;
[0021] Step S25, performing the same operations as steps S14-S15 until the fluorescence intensity value is obtained after fluorescence detection, and then drawing a standard curve after calculating the average fluorescence intensity to obtain a regression equation; the standard curve uses the concentration of the standard (μg / mL) as the abscissa and the fluorescence intensity value (FI) as the ordinate;
[0022] Step S26, substitute the sample fluorescence intensity obtained in step S1 into the standard curve regression equation to obtain the corresponding concentration (if the fluorescence intensity of the plasma sample is not within the optimal range of the standard curve, a constant coefficient will be used to adjust the fluorescence intensity of the sample to the corresponding range for concentration calculation). Subsequent concentration calculations need to combine the dilution multiple and the corresponding coefficient, and the unit of the final sample F10P concentration will be the equivalent fluorescence intensity of μg quinine sulfate / ml, referred to as μg / mL.
[0023] Furthermore, the specific operation of step S14 is: placing the EP tube on an oscillator and oscillating for 15 seconds to fully mix, then centrifuging the EP tube at a speed of 3000 rpm and a temperature of 4°C for 10 minutes, transferring the supernatant after centrifugation to a new EP tube, and centrifuging the supernatant at a speed of 3000 rpm and a temperature of 4°C for 10 minutes.
[0024] Furthermore, the Corning plate is a 96-well black fluorescent ELISA plate.
[0025] Furthermore, the concentration of the quinine sulfate solution is 5 μg / mL.
[0026] Furthermore, the specific operation of preparing the 5 μg / mL quinine sulfate solution is as follows: weigh 0.1000 g of quinine sulfate fluorescent standard substance, dissolve it with 0.05 mol / L H2SO4 solution and transfer it to a 100 mL volumetric flask, dilute it to the scale with 0.05 mol / L H2SO4 solution, and shake well; take 0.5 mL of the solution in a 100 mL volumetric flask, dilute it to the scale with 0.05 mol / L H2SO4 solution, and shake well.
[0027] Further, the specific operation of step S21 is: take 2.717 mL of concentrated sulfuric acid and dilute it to a 1000 mL volumetric flask with pure water to obtain 1000 mL of 0.05 mol / L H2SO4 solution, wherein the solute mass fraction is 98% and the density is 1.84 g / cm 3 .
[0028] Compared with the prior art, the present invention has the following beneficial effects:
[0029] 1. The present invention standardizes the FlOPs detection technology, including standardized detection procedures and standard reference substance control schemes. The standard reference substance control scheme uses quinine sulfate solution with a concentration of 3.0-6.0 μg / mL as the standard reference substance, and combines with an ELISA instrument to perform FlOP_360 and FlOP_400 detection, which is highly reliable and stable.
[0030] 2. The present invention is helpful for developing a standardized rapid FlOPs test kit with low price, high specificity and wide application range. The normal value range of FlOPs in the population is determined by FlOPs detection technology, which helps to screen people with abnormal oxidative damage levels and give corresponding suggestions, thereby reducing the risk of oxidative damage-related diseases in the population (such as coronary heart disease, osteoporosis, etc.). It is not only suitable for major hospitals, but also for communities and families, making it convenient for people to easily detect the level of oxidative damage in their bodies in life, and then change their living habits, prevent diseases or seek medical treatment in advance. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 It is a detection flow chart of the present invention.
[0032] Figure 2 The present invention is a flow chart for obtaining the fluorescence intensity of a plasma sample to be tested.
[0033] Figure 3 Flow chart for obtaining the concentration of oxidative damage products of a sample according to the present invention. DETAILED DESCRIPTION
[0034] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0035] The specific implementation of the present invention is described in detail below in conjunction with specific embodiments.
[0036] like Figure 1 As shown, a method for detecting oxidative damage based on fluorescent oxidation products provided by an embodiment of the present invention comprises the following steps:
[0037] Step S1, detecting the fluorescence intensity of sample plasma; specifically comprising the following steps:
[0038] Step S11, thawing / cooling: centrifuge (at a speed of 3000 rpm and a temperature of 4°C for 10 min) to extract the blood sample to obtain a plasma sample. The plasma sample stored in the ultra-low temperature refrigerator is placed in a 4°C refrigerator for thawing when used; the newly collected centrifuged plasma sample also needs to be placed in a 4°C refrigerator for cooling (subsequent operation steps are all performed in a 4°C environment);
[0039] Step S12, preparing an extractant: using anhydrous ethanol and ether in a volume ratio of 3:1;
[0040] Step S13, preparing plasma and extractant: mixing plasma and extractant at a volume ratio (μL) of 1:20, preparing three tubes, each with a solution volume of 1300 μL, to obtain three sets of parallel ratios;
[0041] Step S14, sample processing: the EP tube was placed on an oscillator for 15 seconds to allow the extractant and the plasma to be fully mixed, and then the EP tube was centrifuged at a speed of 3000 rpm and a temperature of 4°C for 10 minutes, and the supernatant after centrifugation was transferred to a new EP tube, and the supernatant was centrifuged at a speed of 3000 rpm and a temperature of 4°C for 10 minutes;
[0042] Step S15, detection: the three groups of solutions with parallel proportions were placed in three Corning plates (96-well black fluorescent ELISA plates) for measurement to reduce the difference between the plates. The solution of each EP tube was dropped into three wells (average), and each well was about 300 μL, and then placed in an ELISA reader for detection;
[0043] The parameter settings of the microplate reader include: fluorescence measurement, excitation wavelengths are 360 nm and 400 nm, and the corresponding emission wavelengths are 420 nm and 475 nm; the wavelengths correspond to two FlOP products, namely FlOP_360 and FlOP_400;
[0044] Step S16, calculation: finding the average fluorescence intensity of the three Corning plates at the same volume ratio to obtain the fluorescence intensity of the plasma sample to be tested;
[0045] Step S2, standard reference substance control; specifically comprises the following steps:
[0046] Step S21, prepare 1000mL 0.05mol / L H2SO4 solution: take 2.717mL concentrated sulfuric acid, dilute it to 1000mL volumetric flask with pure water, and obtain 1000mL 0.05mol / L H2SO4 solution, wherein the solute mass fraction is 98% and the density is 1.84g / cm 3 ;
[0047] Step S22, preparing 3.0-6.0 μg / mL quinine sulfate solution as a standard reference;
[0048] Step S23, preparing an extractant: using anhydrous ethanol and ether in a volume ratio of 3:1;
[0049] Step S24, prepare the standard reference substance and the extractant in a volume ratio (μL) of 1:5, 1:10, 1:15, 1:20, 1:25, 1:30, and 1:50 respectively and place them in EP tubes, with the volume of the solution in each tube being 1300 μL;
[0050] Step S25, perform the same operation as steps S14-S15 until the fluorescence intensity value is obtained after fluorescence detection, and then draw a standard curve after calculating the average value of the fluorescence intensity to obtain a regression equation. The standard curve uses the concentration of the standard (μg / mL) as the horizontal axis and the fluorescence intensity value (FI) as the vertical axis;
[0051] Step S26, substitute the sample fluorescence intensity obtained in step S1 into the standard curve regression equation to obtain the corresponding concentration (if the fluorescence intensity of the plasma sample is not within the optimal range of the standard curve, a constant coefficient will be used to adjust the fluorescence intensity of the sample to the corresponding range for concentration calculation). Subsequent concentration calculations need to combine the dilution multiple and the corresponding coefficient, and the unit of the final sample F10P concentration will be the equivalent fluorescence intensity of μg quinine sulfate / ml, referred to as μg / mL.
[0052] In the embodiments of the present invention, the following points should be noted:
[0053] 1. Extraction agent: Try to avoid light and reduce volatility. When using a container, rinse the container 2-3 times with the extraction agent. When adding, first add a small dose and then a large dose.
[0054] 2. Plasma samples: When thawing, make sure the sample is left to stand. When aspirating plasma, first remove the floating film. Secondly, aspirate slowly with the needle to avoid breaking up the flocculent material in the tube and affecting the absorption of the liquid. Be careful not to clog the gun tip or generate bubbles to avoid insufficient aspiration of plasma.
[0055] 3. Pipette: When using a pipette, tighten the tip to prevent the extractant from spilling and dripping into the gaps between the Corning plates. Carefully check the value of the pipette before adding the extractant. When taking the supernatant, do not place the tip of the pipette too low. After centrifugation, drip the liquid wallpaper onto the Corning plate at a slow speed to avoid creating bubbles, and remove any bubbles that may occur.
[0056] 4. Centrifugation: During centrifugation, the hole of the EP tube should face downwards, and the centrifuge parameters should be set in advance, and the temperature should be pre-run to 4°C. Pay attention to the placement of the EP tube when adding samples to avoid missing or adding by mistake.
[0057] 5. The concentration of the standard reference substance quinine sulfate solution can be used in the experiment at 3.0-6.0μg / mL.
[0058] As a preferred embodiment of the present invention, the concentration of the quinine sulfate solution is 5 μg / mL.
[0059] As a preferred embodiment of the present invention, the specific operation of preparing the 5 μg / mL quinine sulfate solution is as follows: weigh 0.1000g of quinine sulfate fluorescent standard substance, dissolve it with 0.05mol / L H2SO4 solution and transfer it to a 100mL volumetric flask, dilute it to the scale with 0.05mol / L H2SO4 solution, and shake well; take 0.5mL of the solution in a 100mL volumetric flask, dilute it to the scale with 0.05mol / LH2SO4 solution, and shake well.
[0060] The present invention is helpful for developing a standardized rapid detection kit for FlOPs that is inexpensive, highly specific and widely applicable. The detection blood sample requirement is low, and the price of a single blood sample on a laboratory scale is only about 50 yuan. After industrialization, it can be as low as 10-30 yuan, or even lower. The standardized rapid detection kit for FlOPs can be used for health examinations of the population in hospitals or communities, and provide a basis for clinical diagnosis through the level of oxidative damage. As a potential biomarker of the disease, FlOPs can be used to assess the degree of development and prognosis of the disease. More high-risk populations can be screened out through FlOPs for early intervention and treatment.
[0061] Example 1: A method for detecting oxidative damage based on fluorescent oxidation products, comprising the following steps:
[0062] Step S1, detecting the fluorescence intensity of sample plasma; specifically comprising the following steps:
[0063] Step S11, thawing / cooling: extract the blood sample by centrifugation (at a speed of 3000 rpm and a temperature of 4°C for 10 min) to obtain a plasma sample, and thaw the plasma sample stored in the ultra-low temperature refrigerator in a 4°C refrigerator;
[0064] Step S12, preparing an extractant: using anhydrous ethanol and ether in a volume ratio of 3:1;
[0065] Step S13, preparing plasma and extractant: mixing plasma and extractant at a volume ratio (μL) of 1:20, preparing three tubes, each with a solution volume of 1300 μL, to obtain three sets of parallel ratios;
[0066] Step S14, sample processing: the EP tube was placed on an oscillator for 15 seconds to allow the extractant and the plasma to be fully mixed, and then the EP tube was centrifuged at a speed of 3000 rpm and a temperature of 4°C for 10 minutes, and the supernatant after centrifugation was transferred to a new EP tube, and the supernatant was centrifuged at a speed of 3000 rpm and a temperature of 4°C for 10 minutes;
[0067] Step S15, detection: the three groups of solutions with parallel proportions were placed in three Corning plates (96-well black fluorescent ELISA plates) for measurement to reduce the difference between the plates. The solution of each EP tube was dropped into three wells (average), and each well was about 300 μL, and then placed in an ELISA reader for detection;
[0068] The parameter settings of the microplate reader include: fluorescence measurement, excitation wavelengths are 360 nm and 400 nm, and the corresponding emission wavelengths are 420 nm and 475 nm; the wavelengths correspond to two FlOP products, namely FlOP_360 and FlOP_400;
[0069] Step S16, calculation: find the average fluorescence intensity of the three Corning plates at the same volume ratio to obtain the fluorescence intensity of the plasma sample to be tested: FlOP_360 is 1509.55; FlOP_400 is 412.55;
[0070] Step S2, standard reference substance control; specifically comprises the following steps:
[0071] Step S21, prepare 1000mL 0.05mol / L H2SO4 solution: take 2.717mL concentrated sulfuric acid, dilute it to 1000mL volumetric flask with pure water, and obtain 1000mL 0.05mol / L H2SO4 solution, wherein the solute mass fraction is 98% and the density is 1.84g / cm 3 ;
[0072] Step S22, preparing a 5.0 μg / mL quinine sulfate solution as a standard reference substance;
[0073] Step S23, preparing an extractant: using anhydrous ethanol and ether in a volume ratio of 3:1;
[0074] Step S24, prepare the standard reference substance and the extractant in a volume ratio (μL) of 1:5, 1:10, 1:15, 1:20, 1:25, 1:30, and 1:50 respectively and place them in EP tubes, with the volume of the solution in each tube being 1300 μL;
[0075] Step S25, perform the same operation as steps S14-S15 until the fluorescence intensity value is obtained after fluorescence detection, and then draw a standard curve after calculating the average fluorescence intensity to obtain a regression equation. The standard curve uses the concentration of the standard (μg / mL) as the horizontal coordinate and the fluorescence intensity value (FI) as the vertical coordinate; the regression equation obtained by detection at 360 / 420nm is y=77567x+3351.8; the regression equation obtained by detection at 400 / 475nm is y=1912.4x+1275.3;
[0076] Step S26, substitute the sample fluorescence intensity obtained in step S1 into the standard curve regression equation to obtain the corresponding concentration, and use the constant coefficient to adjust the sample fluorescence intensity to the corresponding range for concentration calculation. That is, the fluorescence intensity value of the plasma sample FlOP_360 1509.55 and the fluorescence intensity value of FlOP_400 412.55 to be tested are multiplied by the corresponding constant coefficient and substituted into the regression equation to obtain: 0.326μg / mL, 0.196μg / mL. Combined with the dilution multiple and the corresponding coefficient, the final sample FLOP concentration is: FlOP_360 is 0.36μg / mL, and FlOP_400 is 1.029μg / mL.
[0077] Calculate and analyze the coefficient of variation (%): Calculate the mean, standard deviation and coefficient of variation of the fluorescence intensity of the three wells in the plate (coefficient of variation = standard deviation / mean), and take the mean of the three coefficients of variation to obtain the intra-batch coefficient of variation of F10P_360 and F10P_400 of this solution. Calculate the mean, standard deviation and coefficient of variation of the fluorescence intensity of the nine wells between plates to obtain the inter-batch coefficient of variation of F10P_360 and F10P_400.
[0078] When the mixed volume ratio of quinine sulfate solution to the extractant was 1:20 as the test solution, the intra-batch coefficient of variation of FlOP_360 and FlOP_400 was <2.7%, and the inter-batch coefficient of variation was <4.5%; when the mixed volume ratio of plasma sample to the extractant was 1:20 as the test solution, the intra-batch coefficient of variation of FlOP_360 and FlOP_400 was <2.7%, and the inter-batch coefficient of variation was <3.6%;
[0079] Comparative Example 1: Existing methods for detecting oxidative stress biomarkers in plasma are all based on the Shimasaki method, and the detection of FlOPs is achieved by fluorescence spectrophotometer.
[0080] The specific steps include:
[0081] Take the aliquoted plasma samples and extract them with anhydrous ethanol / ether (volume ratio 3:1), with an extraction ratio of plasma: extraction solution = 1:5. Use 0.2 mL of plasma sample and 1 mL of extraction solution for extraction. Mix 0.2 mL of plasma sample with 1 mL of anhydrous ethanol / ether (volume ratio 3:1) in a borosilicate glass tube and mix vigorously on a vortex mixer. Centrifuge the mixed solution at 3000 rpm for 10 minutes, and then add 1 mL of supernatant to a cuvette for spectrophotometer reading. For FlOP_360, the excitation / emission wavelengths are 360 / 420 nm, and for FlOP_400, the excitation / emission wavelengths are 400 / 475 nm. The fluorescence level is expressed as relative fluorescence intensity units per milliliter of plasma, i.e., FI / ml. FlOPs measurement results: The intra-batch coefficient of variation and the inter-batch coefficient of variation of FlOP_360 and FlOP_400 were both <13%.
[0082] It can be seen that compared with the existing methods, the coefficient of variation of the method of the present invention is significantly reduced, thereby improving the accuracy and reliability of FlOPs measurement.
[0083] The above are only preferred embodiments of the present invention. It should be pointed out that, for those skilled in the art, several modifications and improvements can be made without departing from the concept of the present invention. These should also be regarded as the protection scope of the present invention. These will not affect the effect of the implementation of the present invention and the practicality of the patent.
Claims
1. A method for detecting oxidative damage based on fluorescent oxidation products, It is characterized in that The following steps are involved: Step S1, detecting the fluorescence intensity of sample plasma; specifically comprising the following steps: Step S11, thawing / cooling: extracting a blood sample by centrifugation to obtain a plasma sample. When using, thaw the pre-frozen plasma sample in a 4°C refrigerator or cool the newly collected centrifuged plasma sample to a 4°C refrigerator; Step S12, preparing an extractant: using anhydrous ethanol and ether in a volume ratio of 3:1; Step S13, preparing plasma and extractant: mixing plasma and extractant at a volume ratio of 1:20, preparing three tubes, each tube having a solution volume of 1300 μL; Step S14, sample processing: placing the EP tube on a shaker for shaking, then centrifuging the EP tube, after the centrifugation is completed, transferring the supernatant in the EP tube to a new EP tube, and centrifuging again; Step S15, detection: the three sets of parallel solutions are placed in three Corning plates for measurement, the solution of each EP tube is dripped into three wells, and the plate is placed in an ELISA reader for detection; The parameter settings of the microplate reader include: fluorescence measurement, excitation wavelengths are 360 nm and 400 nm, and the corresponding emission wavelengths are 420 nm and 475 nm; the wavelengths correspond to two FlOP products, namely FlOP_360 and FlOP_400; Step S16, calculation: finding the average fluorescence intensity of the three Corning plates at the same volume ratio to obtain the fluorescence intensity of the plasma sample to be tested; Step S2, standard reference substance control; specifically comprises the following steps: Step S21, prepare 1000mL 0.05mol / L H 2 SO 4 Solution; Step S22, preparing 3.0-6.0 μg / mL quinine sulfate solution as a standard reference; Step S23, preparing an extractant: using anhydrous ethanol and ether in a volume ratio of 3:1; Step S24, prepare standard reference substances and extractants at volume ratios of 1:5, 1:10, 1:15, 1:20, 1:25, 1:30, and 1:50 respectively and place them in EP tubes, with the volume of solution in each tube being 1300 μL; Step S25, performing the same operations as steps S14-S15 until the fluorescence intensity value is obtained after the fluorescence detection, and then drawing a standard curve after the average fluorescence intensity is obtained to obtain a regression equation; the standard curve takes the concentration of the standard as the horizontal axis and the fluorescence intensity value as the vertical axis; Step S26, substituting the sample fluorescence intensity obtained in step S1 into the standard curve regression equation to obtain the corresponding concentration; combining the dilution multiple and the corresponding coefficient for subsequent concentration calculation, the final unit of the sample F10P concentration is the equivalent fluorescence intensity of μg quinine sulfate / ml, referred to as μg / mL; If the fluorescence intensity of the plasma sample is not within the optimal range of the standard curve, a constant coefficient is used to adjust the fluorescence intensity of the sample to the corresponding range for concentration calculation.
2. The method for detecting oxidative damage based on fluorescent oxidation products according to claim 1, It is characterized in that The specific operation of step S14 is: placing the EP tube on an oscillator and shaking for 15 seconds to fully mix, then centrifuging the EP tube at a speed of 3000 rpm and a temperature of 4°C for 10 minutes, transferring the supernatant after centrifugation to a new EP tube, and centrifuging the supernatant at a speed of 3000 rpm and a temperature of 4°C for 10 minutes.
3. The method for detecting oxidative damage based on fluorescent oxidation products according to claim 1, It is characterized in that The Corning plate is a 96-well black fluorescent ELISA plate.
4. The method for detecting oxidative damage based on fluorescent oxidation products according to claim 1, It is characterized in that The concentration of the quinine sulfate solution is 5 μg / mL.
5. The method for detecting oxidative damage based on fluorescent oxidation products according to claim 4, It is characterized in that The specific operation of preparing the 5 μg / mL quinine sulfate solution is as follows: weigh 0.1000 g of quinine sulfate fluorescent standard substance, add 0.05 mol / L H 2 SO 4 The solution was dissolved and transferred to a 100 mL volumetric flask and diluted with 0.05 mol / L H 2 SO 4 Dilute the solution to the mark and shake well; take 0.5 mL of the solution into a 100 mL volumetric flask and add 0.05 mol / L H 2 SO 4 Dilute the solution to volume and shake well.
6. The method for detecting oxidative damage based on fluorescent oxidation products according to claim 1, It is characterized in that The specific operation of step S21 is: take 2.717 mL of concentrated sulfuric acid and dilute it to 1000 mL with pure water. Volumetric flask, then 1000mL of 0.05mol / L H 2 SO 4 solution, wherein the mass fraction of solute is 98%, Density: 1.84 g / cm 3 .
